TWOSTONE&Sons Inc. Logo

TWOSTONE&Sons Inc.

An engineer platform providing IT talent and marketing services for corporate digital transformation.

7352 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
渋谷区渋谷2−22−3渋谷東口ビル6F
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

TWOSTONE&Sons Inc. is a holding company that provides solutions centered on its engineer platform. The company's operations are primarily organized into two segments: Engineer Platform Services and Marketing Platform Services. It specializes in supplying IT engineering resources to corporate clients, supporting their digital transformation (DX) initiatives, and offering digital marketing services. Key offerings include the IT talent platforms Midworks and TechStars, and the programming school tech boost, which nurtures engineering talent. Operating under the vision "BREAK THE RULES," the company aims to solve social challenges by creating new value and challenging conventional business norms through its technology-focused services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-04-30 09:26
Regulatory News Service
臨時報告書
Japanese 18.9 KB
2025-04-30 09:25
Regulatory News Service
臨時報告書
Japanese 33.8 KB
2025-04-14 08:37
Interim Report
半期報告書-第12期(2024/09/01-2025/08/31)
Japanese 246.6 KB
2025-04-14 08:37
Regulatory News Service
確認書
Japanese 8.8 KB
2024-11-29 07:54
Post-Annual General Meeting Information
臨時報告書
Japanese 24.0 KB
2024-11-28 07:51
Governance Information
内部統制報告書-第11期(2023/09/01-2024/08/31)
Japanese 23.6 KB
2024-11-28 07:50
Registration Form
確認書
Japanese 8.7 KB
2024-11-28 07:49
Annual Report
有価証券報告書-第11期(2023/09/01-2024/08/31)
Japanese 1.5 MB
2024-11-25 08:54
Regulatory News Service
臨時報告書
Japanese 18.6 KB
2024-10-08 08:01
Regulatory News Service
臨時報告書
Japanese 35.5 KB
2024-07-12 08:34
Report Publication Announcement
確認書
Japanese 8.8 KB
2024-07-12 08:33
Quarterly Report
四半期報告書-第11期第3四半期(2024/03/01-2024/05/31)
Japanese 210.8 KB
2024-05-31 09:52
Regulatory News Service
訂正臨時報告書
Japanese 35.9 KB
2024-05-16 08:56
Share Issue/Capital Change
臨時報告書
Japanese 37.2 KB
2024-04-25 02:00
Share Issue/Capital Change
訂正臨時報告書
Japanese 34.3 KB

Automate Your Workflow. Get a real-time feed of all TWOSTONE&Sons Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for TWOSTONE&Sons Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571
NATURECELL CO.,LTD. Logo
Biotech company developing stem cell therapies, food, beverages, and cosmetics.
South Korea 007390
A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan 4196
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia N/A
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan 2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan 4893

Talk to a Data Expert

Have a question? We'll get back to you promptly.